Top

Published in:

01-07-2013 | Laboratory Investigation

The cytotoxic effect of β-elemene against malignant glioma is enhanced by base-excision repair inhibitor methoxyamine

Authors: Yongjian Zhu, Jue Hu, Fang Shen, Hong Shen, Weiguo Liu, Jianmin Zhang

Published in: Journal of Neuro-Oncology | Issue 3/2013

Abstract

This study investigated the effects of β-elemene + methoxyamine, a DNA base-excision repair inhibitor, on the inhibition of glioma growth. We treated C6 and SHG44 glioma cells with β-elemene and methoxyamine individually or in combinations, and subsequently analyzed cellular survivals by MTT assay. Comet assay, γ-H2AX focus formation assay and Western-blot were performed to investigate whether the observed cytotoxicity was associates with DNA damages. Finally, a xenograft tumor model was established in nude mice with C6 cells to analyze in vivo tumor inhibition effects of β-elemene, which was followed by determination of the expression of anti-apoptotic protein Bcl-2 via immunohistochemistry staining. Results showed that β-elemene could significantly inhibit the growth of glioma cells in a dose- and time-dependent manner. The combination of methoxyamine with β-elemene could result in a greater extent of DNA injuries in vitro. Furthermore, in vivo tumors exhibited a marked shrinkage in volume in β-elemene + methoxyamine treatment group. Immunohistochemistry analysis of the tumor tissues showed a distinctive decrease in Bcl-2 staining in β-elemene (56 %) and β-elemene + methoxyamine (36 %) groups when compared with the negative control (77 %). In conclusion, β-elemene exhibits a significant cytotoxic effect against glioma cells both in vitro and in vivo, which is likely to be mediated by its potential to damage tumor cell DNA and activate apoptotic pathway. Such growth inhibition effect of β-elemene could be potentiated by methoxyamine co-administration. Therefore, a combination of the two agents as a novel chemotherapeutic option for glioma merits further investigations.

Available only for authorised users

Sanson M (2008) Editorial review: targets for glioma treatment: from bench to bedside. Curr Opin Oncol 20:650–651PubMedCrossRef

Wang XS, Yang W, Tao SJ et al (2006) Effect of delta-elemene on Hela cell lines by apoptosis induction. Yakugaku Zasshi 126:979–990PubMedCrossRef

Xie CY, Yang W, Li M et al (2009) Cell apoptosis induced by delta-elemene in colorectal adenocarcinoma cells via a mitochondrial-mediated pathway. Yakugaku Zasshi 129:1403–1413PubMedCrossRef

Xu L, Tao S, Wang X et al (2006) The synthesis and anti-proliferative effects of beta-elemene derivatives with mTOR inhibition activity. Bioorg Med Chem 14:5351–5356PubMedCrossRef

Rui D, Xiaoyan C, Taixiang W et al (2007) Elemene for the treatment of lung cancer. Cochrane Database Syst Rev 17(4):CD006054

Sun Y, Liu G, Zhang Y et al (2009) Synthesis and in vitro anti-proliferative activity of beta-elemene monosubstituted derivatives in HeLa cells mediated through arrest of cell cycle at the G1 phase. Bioorg Med Chem 17:1118–1124PubMedCrossRef

Tao L, Zhou L, Zheng L et al (2006) Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo. Cancer Chemother Pharmacol 58:24–34PubMedCrossRef

Wang G, Li X, Huang F et al (2005) Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci 62:881–893PubMedCrossRef

Wang K, Li Z, Chen Y et al (2005) The pharmacokinetics of a novel anti-tumor agent, beta-elemene, in Sprague-Dawley rats. Biopharm Drug Dispos 26:301–307PubMedCrossRef

10.

Li QQ, Wang G, Zhang M et al (2009) Beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis. Oncol Rep 22:161–170PubMed

11.

Mathews LA, Cabarcas SM, Farrar WL (2011) DNA repair: the culprit for tumor-initiating cell survival? Cancer Metastasis Rev 30:185–197CrossRef

12.

Klein TJ, Glazer PM (2010) The tumor microenvironment and DNA repair. Semin Radiat Oncol 20:282–287PubMedCrossRef

13.

Higgins GS, Prevo R, Lee YF et al (2010) A small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radiosensitization by POLQ knockdown. Cancer Res 70:2984–2993PubMedCrossRef

14.

Seo Y, Kinsella TJ (2009) Essential role of DNA base excision repair on survival in an acidic tumor microenvironment. Cancer Res 69:7285–7293PubMedCrossRef

15.

Zhang J, Stevens MF, Bradshaw TD (2012) Temozolomide: mechanisms of action, repair and resistance. Curr Mol Pharmacol 5:102–114PubMed

16.

Leonetti C, Biroccio A, Graziani G et al (2012) Targeted therapy for brain tumours: role of PARP inhibitors. Curr Cancer Drug Targets 12:218–236PubMedCrossRef

17.

Goellner EM, Svilar D, Almeida KH et al (2012) Targeting DNA polymerase ss for therapeutic intervention. Curr Mol Pharmacol 5:68–87PubMed

18.

Tawbi HA, Villaruz L, Tarhini A et al (2011) Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours. Br J Cancer 105:773–777PubMedCrossRef

19.

Bulgar AD, Weeks LD, Miao Y et al (2012) Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair. Cell Death Dis 3:e252PubMedCrossRef

20.

Berridge MV, Tan AS (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303:474–482PubMedCrossRef

21.

Olive PL, Banath JP (2006) The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 1:23–29PubMedCrossRef

22.

Muslimovic A, Ismail IH, Gao Y et al (2008) An optimized method for measurement of gamma-H2AX in blood mononuclear and cultured cells. Nat Protoc 3:1187–1193PubMedCrossRef

23.

Barth RF, Kaur B (2009) Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol 94:299–312PubMedCrossRef

24.

Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466PubMedCrossRef

25.

Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573–584PubMedCrossRef

26.

Perry J, Laperriere N, Zuraw L et al (2007) Adjuvant chemotherapy for adults with malignant glioma: a systematic review. Can J Neurol Sci 34:402–410PubMed

27.

Pang BC, Wan WH, Lee CK et al (2007) The role of surgery in high-grade glioma–is surgical resection justified? a review of the current knowledge. Ann Acad Med Singapore 36:358–363PubMed

28.

Tsao MN, Mehta MP, Whelan TJ et al (2005) The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Int J Radiat Oncol Biol Phys 63:47–55PubMedCrossRef

29.

Neyns B, Sadones J, Chaskis C et al (2005) The role of chemotherapy in the treatment of low-grade glioma. A review of the literature. Acta Neurol Belg 105:137–143

30.

Chen W, Lu Y, Wu J et al (2010) Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis. Cancer Chemother Pharmacol 67(4):799–808PubMedCrossRef

31.

Li QQ, Wang G, Zhang M et al (2009) beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis. Oncol Rep 22:161–170

32.

Li X, Wang G, Zhao J et al (2005) Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol Life Sci 62:894–904PubMedCrossRef

33.

Wang Y, Fang MY (2006) Effect of ginseng saponin, arsenic trioxide, beta-elemene combined with CTX on telomere-telomerase system in K562 cell line. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14:1089–1095

34.

Wu XS, Xie T, Lin J et al (2009) An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas. J Pharm Pharmacol 61:1653–1656PubMedCrossRef

35.

Yao YQ, Ding X, Jia YC et al (2008) Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett 264:127–134PubMedCrossRef

36.

Humlova Z (2002) Protooncogene bcl-2 in process of apoptosis. Review article. Sb Lek 103:419–425

37.

Yuan J, Gu ZL, Chou WH et al (1999) Elemene induces apoptosis and regulates expression of bcl-2 protein in human leukemia K562 cells. Zhongguo Yao Li Xue Bao 20:103–106PubMed

38.

Zhang H, Xu F, Xie T et al (2012) Beta-elemene induces glioma cell apoptosis by downregulating survivin and its interaction with hepatitis B X-interacting protein. Oncol Rep 28:2083–2090PubMed

39.

Kao GD, Jiang Z, Fernandes AM et al (2007) Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation. J Biol Chem 282:21206–21212PubMedCrossRef

40.

Zhu T, Zhao Y, Zhang J et al (2011) ss-Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6. Int J Oncol 38:419–426PubMed

41.

Zhu T, Xu Y, Dong B et al (2011) Beta-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor beta and induces sensitization to cisplatin. Oncol Rep 26:405–413PubMed

42.

Zhao YS, Zhu TZ, Chen YW et al (2012) Beta-elemene inhibits Hsp90/Raf-1 molecular complex inducing apoptosis of glioblastoma cells. J Neurooncol 107:307–314PubMedCrossRef

43.

Riemenschneider MJ, Reifenberger G (2009) Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches. Curr Opin Neurol 22:619–624PubMedCrossRef

44.

Quillien V, Vauleon E, Saikali S et al (2011) MGMT analysis in gliomas. Bull Cancer 98:291–303PubMed

45.

Dinnes J, Cave C, Huang S et al (2002) A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma. Br J Cancer 86:501–505PubMedCrossRef

46.

Dinnes J, Cave C, Huang S et al (2001) The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review. Health Technol Assess 5:1–73PubMed

47.

Zhao J, Li QQ, Zou B et al (2007) In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma. Int J Oncol 31:241–252PubMed

Title: The cytotoxic effect of β-elemene against malignant glioma is enhanced by base-excision repair inhibitor methoxyamine
Authors: Yongjian Zhu
Jue Hu
Fang Shen
Hong Shen
Weiguo Liu
Jianmin Zhang
Publication date: 01-07-2013
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2013
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-013-1136-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The cytotoxic effect of β-elemene against malignant glioma is enhanced by base-excision repair inhibitor methoxyamine

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2013

Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma

Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors

Lyophilized brain tumor specimens can be used for histologic, nucleic acid, and protein analyses after 1 year of room temperature storage

Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas

Valproic acid and its inhibition of tumor growth in systemic malignancies: beyond gliomas

Histopathological correlates with survival in reoperated glioblastomas